Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Eye, Ear & Vision

Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review

In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti-vascular endothelial growth factor agents, and steroid implants with a focus on the new fluocinolone acetonide implant, ILUVIEN®.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This literature review describes diabetic macular oedema and compares current treatments, including laser, anti-VEGF agents and steroid implants, with a focus on the fluocinolone acetonide implant ILUVIEN. The authors report that the FAME studies and real-world studies support its use in resolving oedema and improving vision and macular anatomy in this patient group.

Who or what was studied
Patients with diabetic macular oedema
Limits stated in the abstract
The abstract does not state the number of studies or patients included, and does not report the certainty of the evidence.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Laser. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Eye, Ear & Vision

Diabetic macular edema

Although treatments for DME have improved significantly over the past decades, the burden of this disease remains high for patients and the healthcare system alike.

Study · February 10, 2021 · Ixcamey M et al.